DNA Microarray Market Report 2026

The dna microarray market size has grown rapidly in recent years. It will grow from $3.78 billion in 2025 to $4.24 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to genomic research growth, early gene expression studies, pharmaceutical r&d needs, academic research funding, disease biomarker discovery.

The dna microarray market size is expected to see rapid growth in the next few years. It will grow to $6.36 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to precision medicine research, integration with ai analytics, translational genomics growth, drug target identification, personalized healthcare research. Major trends in the forecast period include growing use of gene expression profiling, expansion of microarray applications in research, increased adoption in biomarker discovery, integration with advanced data analysis tools, demand for high-throughput genomic screening.

The rapid adoption of personalized medicine is expected to drive the growth of the DNA microarray market in the coming years. Personalized medicine involves tailoring medical treatment to the unique characteristics of each patient, including genetic, environmental, and lifestyle factors. Its adoption is rising due to advances in ‘omics’ technologies, improved data-integration capabilities, and growing awareness among healthcare professionals and patients, making individualized therapies more feasible and accessible. The DNA microarray market supports this trend by enabling gene expression profiling and genomic analysis, which form the basis for precision diagnostics and personalized treatment plans. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based non-profit organization, reported that the U.S. Food and Drug Administration (FDA) approved 16 novel personalized therapies for rare diseases in 2023, compared to 6 in 2022, indicating accelerated adoption of precision medicine approaches. Therefore, the rising uptake of personalized medicine is fueling the growth of the DNA microarray market.

Companies in the DNA microarray market are focusing on developing advanced technologies, such as rapid-turnaround microarray platforms, to enhance workflow efficiency, speed up data delivery, and strengthen competitiveness. A rapid-turnaround microarray platform is a high-resolution genomic analysis system designed to produce comprehensive results within a shortened timeframe, such as two days, supporting faster research progress and timely clinical decision-making. For instance, in August 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, launched the Applied Biosystems CytoScan HD Accel array, a chromosomal microarray that offers a leading two-day turnaround and improved whole-genome coverage across more than 5,000 key genomic regions. This platform enables cytogenetic laboratories to increase productivity, improve efficiency, and generate more actionable insights for prenatal, postnatal, and oncology research.

In May 2023, Thermo Fisher Scientific, a US-based scientific services company, partnered with the Qatar Genome Program (QGP) for an undisclosed amount. Through this collaboration, Thermo Fisher aims to advance precision medicine initiatives for Arab populations by co-developing a custom Axiom genotyping array that leverages whole-genome sequencing data from 19 Arab countries. The Qatar Genome Program (QGP) is a Qatar-based national population-level research initiative focused on building genomic datasets to support precision health programs.

Major companies operating in the dna microarray market are Roche Holding AG, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., bioMérieux SA, Schott AG, Bio-Rad Laboratories Inc., QIAGEN N.V., Bioneer Corporation, CapitalBio Technology Co. Ltd., Eurofins Genomics LLC, Savyon Diagnostics Ltd., Oxford Gene Technology, Sengenics Corporation LLC, Affymetrix, BioCat GmbH, Scienion AG, LC Sciences, Arrayit Corporation, Akonni Biosystems Inc., Arraystar Inc., Febit Holding GmbH.

North America was the largest region in the DNA microarray market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna microarray market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dna microarray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the dna microarray market by increasing costs of imported microarray chips, scanners, and reagents. Research institutes in North America and Europe are most affected due to equipment imports, while Asia-Pacific faces higher setup costs. These tariffs raise research expenses by increasing procurement and operational costs for gene expression and genotyping studies, slowing project timelines and limiting large-scale adoption in cost-sensitive academic and clinical research settings. However, they encourage local manufacturing of genomic tools, regional production of microarray consumables, and increased investment in domestic life sciences instrumentation to reduce reliance on imported technologies over the long term.

The dna microarray market research report is one of a series of new reports that provides dna microarray market statistics, including dna microarray industry global market size, regional shares, competitors with a dna microarray market share, detailed dna microarray market segments, market trends and opportunities, and any further data you may need to thrive in the dna microarray industry. This dna microarray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A deoxyribonucleic acid (DNA) microarray is a versatile tool in molecular biology that enables the simultaneous measurement of expression levels for thousands of genes. It is composed of tiny spots, or probes, containing known DNA sequences fixed on a solid surface. When a sample with fluorescently labeled DNA is applied to the microarray, the intensity of fluorescence at each spot reflects the expression level of the corresponding gene, allowing researchers to analyze gene expression patterns and identify biomarkers linked to various diseases or experimental conditions.

The main types of DNA microarrays include complementary DNA microarrays, oligonucleotide DNA microarrays, and others. Complementary DNA microarrays are widely used research tools for analyzing gene expression across large numbers of genes simultaneously. They are applied in gene expression analysis, genotyping, and other areas, and are utilized by end users such as pharmaceutical and biotechnology companies, diagnostic centers, hospitals and clinics, academic and research institutes, and others.

The DNA microarray market consists of sales of DNA microarray chips, microarray scanners, and microarray printers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.